AXCELIS TECHNOLOGIES INC
Business
Axcelis Technologies designs, manufactures and services ion implantation equipment used in semiconductor chip fabrication, selling primarily to leading global chip manufacturers. The company offers a complete line of Purion and Ovation ion implanter systems across high energy, high current and medium current categories, as well as legacy equipment. Axcelis operates two main business areas: systems (ion implantation equipment) and aftermarket services including used tools, spare parts, upgrades and maintenance. The company sells globally through direct sales offices in the U.S., Asia, Europe and other regions, with the majority of revenue derived from international markets.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 839 | 1,018 | 1,131 | 920 | 662 | |
| Total cost of revenue | 462 | 563 | 639 | 518 | 376 | |
| Gross profit | 377 | 455 | 491 | 402 | 286 | |
| Research and development | 109 | 105 | 97 | 78 | 65 | |
| Sales and marketing | 65 | 68 | 63 | 54 | 48 | |
| General and administrative | 83 | 70 | 66 | 57 | 46 | |
| Total operating expenses | 258 | 244 | 226 | 189 | 159 | |
| Income from operations | 119 | 211 | 266 | 212 | 127 | |
| Interest income | 21 | 24 | 18 | 5 | 209,000 | |
| Interest expense | −5 | −5 | −5 | −6 | — | |
| Other, net | 3 | 539,000 | −48,000 | −6 | −2 | |
| Total other income | 19 | 19 | 13 | −7 | −7 | |
| Income before income taxes | 138 | 230 | 279 | 205 | 120 | |
| Income tax provision | 18 | 29 | 32 | 22 | 22 | |
| Net income | 120 | 201 | 246 | — | — | |
| Basic | 3.81 | 6.17 | 7.52 | 5.54 | 2.94 | |
| Diluted | 3.8 | 6.15 | 7.43 | 5.46 | 2.88 | |
| Basic weighted average shares of common stock | 32 | 33 | 33 | 33 | 34 | |
| Diluted weighted average shares of common stock | 32 | 33 | 33 | 34 | 34 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 145 | 124 | 167 | 186 | 295 | |
| Short-term investments | 229 | 448 | 339 | 247 | — | |
| Accounts receivable, net | 168 | 203 | 218 | 170 | 104 | |
| Inventories, net | 329 | 282 | 306 | 242 | 195 | |
| Prepaid income taxes | 5 | 6 | — | — | — | |
| Prepaid expenses and other current assets | 67 | 60 | 49 | 33 | 25 | |
| Total current assets | 943 | 1,124 | 1,080 | 878 | 619 | |
| Property, plant and equipment, net | 56 | 54 | 54 | 40 | 35 | |
| Operating lease assets | 29 | 30 | 31 | 12 | 9 | |
| Finance lease assets, net | 14 | 15 | 17 | 18 | 19 | |
| Long-term restricted cash | 11 | 8 | 7 | 752,000 | 757,000 | |
| Deferred income taxes | 80 | 68 | 53 | 32 | 35 | |
| Long-term investments | 182 | — | — | — | — | |
| Other assets | 46 | 51 | 41 | 34 | 34 | |
| Total assets | 1,361 | 1,349 | 1,282 | 1,014 | 753 | |
| Accounts payable | 42 | 47 | 54 | 62 | 38 | |
| Accrued compensation | 34 | 26 | 31 | 36 | 31 | |
| Warranty | 10 | 13 | 14 | 8 | 6 | |
| Income taxes | 11 | — | 6 | 4 | 887,000 | |
| Deferred revenue | 66 | 95 | 165 | 123 | 60 | |
| Current portion of finance lease obligation | 2 | 1 | 2 | 1 | 979,000 | |
| Other current liabilities | 33 | 26 | 13 | 13 | 13 | |
| Total current liabilities | 198 | 208 | 285 | 248 | 150 | |
| Long-term finance lease obligation | 41 | 42 | 44 | 45 | 46 | |
| Long-term deferred revenue | 43 | 44 | 46 | 31 | 8 | |
| Other long-term liabilities | 45 | 43 | 42 | 22 | 10 | |
| Total liabilities | 327 | 336 | 417 | 346 | 214 | |
| Commitments and contingencies (Note 16) | — | — | — | — | — | |
| Common stock, $0.001 par value, 75,000 shares authorized; 30,717 shares issued and outstanding at December 31, 2025; 32,365 shares issued and outstanding at December 31, 2024 | 31,000 | 32,000 | 33,000 | 33,000 | 33,000 | |
| Additional paid-in capital | 533 | 549 | 547 | 550 | 560 | |
| Retained earnings | 504 | 470 | 320 | 119 | −23 | |
| Accumulated other comprehensive loss | −2 | −6 | −2 | −2 | 2 | |
| Total stockholders' equity | 1,035 | 1,013 | 865 | 667 | 539 | |
| Total liabilities and stockholders' equity | 1,361 | 1,349 | 1,282 | 1,014 | 753 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 120 | 201 | 246 | 183 | 99 | |
| Depreciation and amortization | 18 | 16 | 13 | 12 | 11 | |
| Deferred income taxes | −11 | −16 | −20 | 9 | 20 | |
| Stock-based compensation expense | 21 | 21 | 18 | 13 | 12 | |
| Provision for doubtful accounts | — | 3 | 1 | — | — | |
| Provision for excess and obsolete inventory | 4 | 6 | 5 | 5 | 4 | |
| Accretion of discounts and premiums on short-term and long-term investments | −4 | −12 | −12 | — | — | |
| Unrealized currency gain on foreign denominated transactions | 2 | 8 | 2 | 6 | — | |
| Mark-to-market adjustment on forward exchange contracts | −435,000 | −267,000 | — | — | — | |
| Accounts receivable | 37 | 7 | −51 | −67 | −18 | |
| Inventories | −42 | 6 | −70 | −58 | −39 | |
| Prepaid expenses and other current assets | −5 | −12 | −16 | −7 | −4 | |
| Accounts payable and other current liabilities | 6 | −413,000 | −8 | 31 | 22 | |
| Deferred revenue | −30 | −71 | 56 | 86 | 45 | |
| Income taxes | 13 | −9 | 4 | 3 | 253,000 | |
| Other assets and liabilities | −11 | −6 | −12 | −625,000 | −2 | |
| Net cash provided by operating activities | 118 | 141 | 157 | 216 | 150 | |
| Expenditures for property, plant and equipment and capitalized software | −11 | −12 | −21 | −11 | −9 | |
| Purchases of short-term and long-term investments | −646 | −539 | −389 | — | — | |
| Maturities and sales of short-term investments | 687 | 443 | 309 | — | — | |
| Net cash provided by (used in) investing activities | 30 | −109 | −101 | −257 | −9 | |
| Net settlement on restricted stock grants | −5 | −12 | −17 | −10 | −7 | |
| Repurchase of common stock | −121 | −60 | −52 | −57 | −50 | |
| Proceeds from Employee Stock Purchase Plan purchases | 2 | 2 | 2 | 2 | 1 | |
| Principal payments on finance lease obligation | −1 | −2 | −1 | −987,000 | −763,000 | |
| Proceeds from exercise of stock options | — | — | 25,000 | 1 | 4 | |
| Net cash used in financing activities | −124 | −71 | −68 | −65 | −52 | |
| Effect of exchange rate changes on cash and cash equivalents | 1 | −4 | −139,000 | −2 | 2 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 25 | −43 | −12 | −109 | 91 | |
| Interest | 5 | 5 | 5 | 5 | 5 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is AXCELIS TECHNOLOGIES INC's CIK number?
AXCELIS TECHNOLOGIES INC's SEC CIK number is 0001113232 (1113232). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find AXCELIS TECHNOLOGIES INC's SEC filings?
All of AXCELIS TECHNOLOGIES INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did AXCELIS TECHNOLOGIES INC last report earnings?
AXCELIS TECHNOLOGIES INC (ACLS) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-26-057147). This is AXCELIS TECHNOLOGIES INC's most recent earnings filing of record — not a forecast of its next earnings date.
What is AXCELIS TECHNOLOGIES INC's most recent earnings 8-K?
AXCELIS TECHNOLOGIES INC's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001104659-26-057147. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View AXCELIS TECHNOLOGIES INC's latest earnings 8-K →
Look up any company's CIK number →